The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...

March 17 (Reuters) - The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics' drug for a type of eye ...

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, has declared March 23-29, 2026, as its first-ever Keratoconus Week. The ...

Women over 50 face increased eye health risks post-menopause due to hormonal shifts. Conditions like dry eye, cataracts, glaucoma, and age-related macular degeneration become more prevalent.

With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...

Scientists found that protein deposits in the retina create unique light patterns for different brain diseases in humans.

After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...

Researchers have found in a new study that advanced periodontal inflammation (stage III–IV) may cause degenerative changes in retinal microvasculature and neural tissues. The increasing severity ...

Researchers develop a 96% accurate AI-powered retinal scan to distinguish between Alzheimer’s and ALS by detecting specific protein deposits.

A common medication may have an unexpected effect on a serious eye condition, new research suggests.